Add BrightSurf on Google Email

Impact Journals LLC


Tumor-derived extracellular vesicles show promise for earlier detection of metastatic risk

Tumor-derived extracellular vesicles exhibit intrinsic organotropism and participate in establishing premetastatic niches, making them promising vehicles for targeted imaging probe delivery. However, current imaging approaches have limitations, including difficulty distinguishing between tumor-derived EVs and normal host cell-derived EVs.

SourceImpact Journals LLC·JournalOncotarget·TypeLiterature review·DateSep 1, 2026

Tumor-infiltrating lymphocyte therapy offers a promising approach for treating solid tumors

Tumor-infiltrating lymphocyte therapy has shown potential in several types of solid tumors, including metastatic melanoma, breast cancer, and ovarian cancer. Despite challenges, the approach has favorable clinical outcomes, and researchers are exploring combination strategies and advanced technologies to improve treatment durability.

SourceImpact Journals LLC·JournalOncotarget·TypeNews article·DateAug 31, 2026

Targeting LRG1 could open new paths for cancer therapy

A review suggests targeting LRG1 could provide a new approach to cancer therapy, with extracellular blockade and intracellular degradation potentially addressing different components of LRG1 biology. This could complement established anti-angiogenic treatments and enhance apoptosis in cancer cells.

SourceImpact Journals LLC·JournalOncoscience·TypeNews article·DateAug 26, 2026

International Molecular Tumor Board explores personalized treatment strategies for a patient with multiple primary cancers

A new precision oncology paper presents a case of a 48-year-old woman with multiple primary cancers, including breast cancer, basal cell carcinoma, ovarian carcinoma, colon cancer, and small bowel adenocarcinoma. The study demonstrates how an international molecular tumor board developed personalized treatment recommendations based on ...

SourceImpact Journals LLC·JournalOncotarget·TypeCase study·DateJul 22, 2026

Rare cervical tumor highlights importance of accurate diagnosis in women with persistent menorrhagia and pelvic pain

A rare case report highlights the challenges of diagnosing cervical angioleiomyoma, a benign tumor presenting symptoms similar to those of common gynecological conditions. The study describes a successful surgical excision and excellent clinical outcome for a young woman with persistent heavy menstrual bleeding and pelvic pain.

SourceImpact Journals LLC·JournalOncoscience·DateJul 15, 2026

Comprehensive individual-patient analysis clarifies life expectancy across rare progeria disorders

A comprehensive systematic review clarifies life expectancy across rare progeria disorders, revealing striking differences among subtypes. The analysis demonstrates that patients with Hutchinson-Gilford progeria syndrome have a median survival of 16 years, while those with mandibuloacral dysplasia type B have a median survival of 37 ye...

SourceImpact Journals LLC·JournalAging-US·TypeSystematic review·DateJul 6, 2026

Active β-catenin identified as a driver of aggressive pediatric osteosarcoma

A new study published in Genes & Cancer identifies activated beta-catenin as a key driver of aggressive pediatric osteosarcoma progression. The researchers found that cells expressing active beta-catenin exhibited enhanced invasive capacity and cancer-associated traits, suggesting a potential therapeutic target for this aggressive cancer.

SourceImpact Journals LLC·JournalGenes & Cancer·TypeNews article·DateJun 9, 2026

Experimental compounds trigger cancer cell death in KRAS-driven pancreatic cancer

Researchers investigated polyisoprenylated cysteinyl amide inhibitors (PCAIs) for their anticancer effects on pancreatic cancer cells with KRAS mutations. The compounds demonstrated strong activity against cell survival, migration, and invasion pathways. PCAI treatment caused hyperactivation of MAPK and PI3K/AKT pathways, leading to ox...

SourceImpact Journals LLC·JournalOncotarget·TypeNews article·DateJun 8, 2026